The Origin and Evolution of Mutations in Acute Myeloid Leukemia

Cited by (1,001)

Items 801–900 of 1,001

1. FLT3‐ITD mutations in acute myeloid leukaemia – molecular characteristics, distribution and numerical variation
   Caroline Engen, Monica Hellesøy, Tim Grob, Adil S. A. Al Hinai, Atle Brendehaug, Line Wergeland, Siv Lise Bedringaas, Randi Hovland, Peter J.M. Valk, Bjørn Tore Gjertsen · 2021 · Molecular Oncology
2. Versatility of stem and progenitor cells and the instructive actions of cytokines on hematopoiesis.
   Geoffrey Brown, Ciarán J. Mooney, Llucia Albertí Servera, Lilly von Muenchow, Kai‐Michael Toellner, Rhodri H. Ceredig, Anton G. Rolink · 2015 · PubMed
3. Relevance of leukemic stem cells in acute myeloid leukemia: heterogeneity and influence on disease monitoring, prognosis and treatment design
   Rolf Wouters, David G. J. Cucchi, Gertjan J.L. Kaspers, Gerrit Jan Schuurhuis, Jacqueline J Cloos · 2014 · Expert Review of Hematology
4. Cardiac stem cell aging and heart failure
   Daniela Cesselli, Aneta Aleksova, Elisa Mazzega, Angela Caragnano, Antonio Paolo Beltrami · 2017 · Pharmacological Research
5. Significance of Clonal Mutations in Bone Marrow Failure and Inherited Myelodysplastic Syndrome/Acute Myeloid Leukemia Predisposition Syndromes
   Eva Johanna Schaefer, Robert Coleman Lindsley · 2018 · Hematology/Oncology Clinics of North America
6. Smc3 is required for mouse embryonic and adult hematopoiesis
   Tianjiao Wang, Brandi K. Glover, Gayla Hadwiger, Christopher A. Miller, Orsola di Martino, John Sutton Welch · 2018 · Experimental Hematology
7. Dynamic clonal hematopoiesis and functional T-cell immunity in a supercentenarian
   Erik B. van den Akker, Stavros Makrodimitris, Marc Hulsman, Martijn H. Brugman, Tatjana Nikolić, Ted Bradley, Quinten Waisfisz, Frank Baas, Marja E. Jakobs, Daphne de Jong et al. · 2020 · Leukemia
8. Combined staurosporine and retinoic acid induces differentiation in retinoic acid resistant acute promyelocytic leukemia cell lines
   Dong-zheng Ge, Yan Sheng, Xun Cai · 2014 · Scientific Reports
9. Clonal haematopoiesis is not prevalent in survivors of childhood cancer
   Grace Collord, Naomi Park, Marina Podestà, Monica Dagnino, Daniela Cilloni, David Jones, Ignacio Varela, Francesco Frassoni, George S. Vassiliou · 2017 · British Journal of Haematology
10. DIS3 isoforms vary in their endoribonuclease activity and are differentially expressed within haematological cancers
    Sophie Rebecca Robinson, Sandra C. Viegas, Rute Gonçalves Matos, Susana Domingues, Marisa Bedir, Stewart Helen, Timothy J. T. Chevassut, Antony W. Oliver, Cecília M. Arraiano, Sarah Faith Newbury · 2018 · Biochemical Journal
11. Occupational and environmental etiology of MDS
    David Bowen · 2013 · Best Practice & Research Clinical Haematology
12. Tracing Dynamics and Clonal Heterogeneity of Cbx7-Induced Leukemic Stem Cells by Cellular Barcoding
    Karin Klauke, Mathilde Broekhuis, Ellen Weersing, Albertina Dethmers-Ausema, Martha Ritsema, Marta Vilà González, Erik Zwart, Leonid V Bystrykh, Gerald de Haan · 2014 · Stem Cell Reports
13. Whole-genome analysis reveals unexpected dynamics of mutant subclone development in a patient with JAK2-V617F-positive chronic myeloid leukemia
    Ivan Sloma, Maria Teresa Mitjavila‐Garcia, Olivier Feraud, Frank Griscelli, Noufϊssa Oudrhiri, Sanaa El Marsafy, Emilie Gobbo, Dominique Divers, Alexis Proust, David M. Smadja et al. · 2017 · Experimental Hematology
14. FLT3-ITD Measurable Residual Disease Monitoring in Acute Myeloid Leukemia Using Next-Generation Sequencing
    Jong-Mi Lee, Silvia Park, In-Sik Hwang, Dain Kang, Byung Sik Cho, Hee‐Je Kim, Ari Ahn, Myungshin Kim, Yonggoo Kim · 2022 · Cancers
15. New Strategies in Acute Myelogenous Leukemia: Leukemogenesis and Personalized Medicine
    Ivana Gojo, Judith E. Karp · 2014 · Clinical Cancer Research
16. Tracking preleukemic cells in vivo to reveal the sequence of molecular events in radiation leukemogenesis
    Tom Verbiest, Rosemary Finnon, Natalie Brown, Lourdes Cruz-Garcia, Paul Finnon, Gráinne O’Brien, Eleanor Ross, Simon D Bouffler, Cheryl L. Scudamore, Christophe Badie · 2018 · Leukemia
17. Beyond regulations at DNA levels: A review of epigenetic therapeutics targeting cancer stem cells
    Shunhao Zhang, Yanji Gong, Chunjie Li, Wenbin Yang, Longjiang Li · 2020 · Cell Proliferation
18. Real-Time Molecular Monitoring in Acute Myeloid Leukemia With Circulating Tumor DNA
    Deepshi Thakral, Ritu Gupta, Ranjit Kumar Sahoo, Pramod Kumar Verma, Indresh Kumar, Sangeeta Vashishtha · 2020 · Frontiers in Cell and Developmental Biology
19. Molecular Targeted Therapy in Myelodysplastic Syndromes: New Options for Tailored Treatments
    Simona Pagliuca, Carmelo Gurnari, Valeria Visconte · 2021 · Cancers
20. Transcription and methylation analyses of preleukemic promyelocytes indicate a dual role for PML/RARA in leukemia initiation
    Charlotte Gaillard, Taku A. Tokuyasu, Galit P. Rosen, Jason R. Sotzen, Adeline Vitaliano-Prunier, Ritu Roy, Emmanuelle A. Passegue, Hugues de Thé, María E. Figueroa, Scott C. Kogan · 2015 · Haematologica
21. The Interplay between PP2A and microRNAs in Leukemia
    Peter P. Ruvolo · 2015 · Frontiers in Oncology
22. Src-like adaptor protein 2 (SLAP2) binds to and inhibits FLT3 signaling
    Sausan A. Moharram, Rohit A. Chougule, Xianwei Su, Tianfeng Li, Jianmin Sun, Hui Zhao, Lars Rönnstrand, Julhash Uddin Kazi · 2016 · Oncotarget
23. WT1 inhibits AML cell proliferation in a p53-dependent manner
    Yiyun Yao, Xingxing Chai, Gong Chen, Li-fang Zou · 2021 · Cell Cycle
24. Analysis of rare driving events in pediatric acute myeloid leukemia
    Sanne Noort, Jolieke G. van Oosterwijk, Jing Ma, Elizabeth A.R. Garfinkle, Stephanie Nance, Michael Patrick Walsh, Guangchun Song, Dirk Reinhardt, Martina Pigazzi, Franco Locatelli et al. · 2022 · Haematologica
25. Reconsidering the usual suspects in age-related hematologic disorders: is stem cell dysfunction a root cause of aging?
    Foteini Fotopoulou, Esther Rodriguez-Correa, Charles Dussiau, Michael D. Milsom · 2024 · Experimental Hematology
26. Mobilization of Hematopoietic Stem Cells with Lenograstim in Healthy Donors: Efficacy and Safety Analysis According to Donor Age
    Massimo Vincenzo Martino, Erminio Bonizzoni, Tiziana Moscato, Anna Grazia Recchia, Roberta Fedele, Giuseppe Alberto Gallo, Giuseppe Console, Giuseppe Messina, Fortunato Morabito · 2015 · Transplantation and Cellular Therapy
27. ASXL1mutations are infrequent in young patients with primary acute myeloid leukemia and their detection has a limited role in therapeutic risk stratification
    Dima El‐Sharkawi, Akbar Ali, Catherine M. Evans, Robert Kerrin Hills, Alan K. Burnett, David C. Linch, Rosemary E. Gale · 2013 · Leukemia & lymphoma/Leukemia and lymphoma
28. A genomic analysis of Philadelphia chromosome-negative AML arising in patients with CML
    Kilannin Krysiak, Matthew J Christopher, Zachary L. Skidmore, Ryan Demeter, Vincent J. Magrini, Jason Kunisaki, Michele O’Laughlin, Eric James Duncavage, Christopher A. Miller, Bradley A. Ozenberger et al. · 2016 · Blood Cancer Journal
29. Therapy-related myeloid neoplasms
    Virginia M. Klimek, Nancy Tray · 2016 · Current Opinion in Hematology
30. Lentiviral Fluorescent Genetic Barcoding for Multiplex Fate Tracking of Leukemic Cells
    Tobias Maetzig, Jens Rüschmann, Lea Sanchez Milde, Courteney K. Lai, Niklas von Krosigk, R. Keith Humphries · 2017 · Molecular Therapy — Methods & Clinical Development
31. Ultra-High-Frequency Reprogramming of Individual Long-Term Hematopoietic Stem Cells Yields Low Somatic Variant Induced Pluripotent Stem Cells
    Kai Wang, Anthony K. Guzman, Zi Yan, Shouping Zhang, Michael Y. Hu, Mehdi Bagheri Hamaneh, Yi‐Kuo Yu, Seda Serra Tolu, Jinghang Zhang, Holly E. Kanavy et al. · 2019 · Cell Reports
32. Integrative Genomic Analysis Reveals Cancer-Associated Gene Mutations in Chronic Myeloid Leukemia Patients with Resistance or Intolerance to Tyrosine Kinase Inhibitor
    Waner Wu, Na Xu, Xuan Zhou, Liang Liu, Yaxian Tan, Jie Denny Luo, Jixian Huang, Jiayue Qin, Juan Wang, Zhimin Li et al. · 2020 · OncoTargets and Therapy
33. Physioxia-induced downregulation of Tet2 in hematopoietic stem cells contributes to enhanced self-renewal
    Arafat Aljoufi, Chi Zhang, James P. Ropa, Wennan Chang, Lakshmi Reddy Palam, Scott H. Cooper, Baskar Ramdas, Maegan L. Capitano, Hal E. Broxmeyer, Reuben Kapur · 2022 · Blood
34. Differences in proliferative capacity of primary human acute myelogenous leukaemia cells are associated with altered gene expression profiles and can be used for subclassification of patients
    Håkon Reikvam, Anne Margrete Oyan, Karl‐Henning Kalland, Randi Hovland, Kimberley Joanne Hatfield, Øystein Bruserud · 2013 · Cell Proliferation
35. Gene mutations in chronic lymphocytic leukemia
    Nisar A. Amin, Sami N. Malek · 2016 · Seminars in Oncology
36. The Impact of the Cellular Origin in Acute Myeloid Leukemia: Learning From Mouse Models
    James Neil Fisher, Natarajaswamy Kalleda, Vaia Stavropoulou, Juerg Schwaller · 2019 · HemaSphere
37. Rationale and Roadmap for Developing Panels of Hotspot Cancer Driver Gene Mutations as Biomarkers of Cancer Risk
    Kelly L. Harris, Meagan B. Myers, Karen L. McKim, Rosalie K. Elespuru, Barbara L. Parsons · 2019 · Environmental and Molecular Mutagenesis
38. The immune receptor Trem1 cooperates with diminished DNA damage response to induce preleukemic stem cell expansion
    Wei Du, Surya P. Amarachintha, Andrew F. Wilson, Qishen Pang · 2016 · Leukemia
39. Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions
    Inderpreet Singh, Abhay Singh · 2023 · Current Oncology Reports
40. The rate of spontaneous mutations in human myeloid cells
    David J. Araten, Ondrej Krejci, Kimberly DiTata, Mark Wunderlich, Katie J. Sanders, Leah B. Zamechek, James C. Mulloy · 2013 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
41. Sequencing the AML Genome, Transcriptome, and Epigenome
    Elaine R. Mardis · 2014 · Seminars in Hematology
42. The role of mutations in the cohesin complex in acute myeloid leukemia
    Claire Mazumdar, Ravindra Majeti · 2016 · International Journal of Hematology
43. Gene Mutations as Emerging Biomarkers and Therapeutic Targets for Relapsed Acute Myeloid Leukemia
    Habsah Aziz, Chow Yock Ping, Hamidah Alias, Nurul‐Syakima Ab Mutalib, Rahman A Jamal · 2017 · Frontiers in Pharmacology
44. Mouse acute leukemia develops independent of self-renewal and differentiation potentials in hematopoietic stem and progenitor cells.
    Fang Dong, Hai-Tao Bai, Xiao-Fang Wang, Shan-Shan Zhang, Zhao Wang, Miner Xie, Sen Zhang, Jinhong Wang, Hao Sha, T. Cheng et al. · 2019 · Blood Advances
45. Clonal approaches to understanding the impact of mutations on hematologic disease development
    Jyoti Nangalia, Emily Mitchell, Anthony Richard Green · 2019 · Blood
46. Characterization of FLT3-ITDmut acute myeloid leukemia: molecular profiling of leukemic precursor cells
    Serena Travaglini, Daniela Francesca Angelini, Valentina Alfonso, Gisella Guerrera, Serena Lavorgna, Mariadomenica Divona, Anna Maria Nardozza, Maria Irno Consalvo, Emiliano Fabiani, Marco De Bardi et al. · 2020 · Blood Cancer Journal
47. Conformational consequences of NPM1 rare mutations: An aggregation perspective in Acute Myeloid Leukemia
    Sara La Manna, Daniele Florio, Concetta Di Natale, Fabiana Napolitano, Anna Maria Malfitano, Paolo A. Netti, Ilaria De Benedictis, Daniela Marasco · 2021 · Bioorganic Chemistry
48. Next Generation Sequencing in Cancer Research and Clinical Application
    Derek Shyr, Qi Liu · 2014 · Apple Academic Press eBooks
49. Molecular Pathways in Clonal Hematopoiesis: From the Acquisition of Somatic Mutations to Transformation into Hematologic Neoplasm
    Charles Gaulin, Katalin Kelemen, Cecilia Arana Yi · 2022 · Life
50. Whole-exome sequencing in del(5q) myelodysplastic syndromes in transformation to acute myeloid leukemia
    Andrea Pellagatti, Marta Fernández‐Mercado, Cristina Di Genua, María José Larráyoz, Sally B. Killick, Hamid Dolatshad, Adam Burns, Marı́a José Calasanz, Anna Schuh, Jacqueline Boultwood · 2013 · Leukemia
51. Evolution of myeloid leukemia in children with Down syndrome
    Satoshi Saida · 2016 · International Journal of Hematology
52. Myeloid Neoplasms Following Solid Organ Transplantation
    Bin Wu, Kimberly Ingersoll, Rachel C. Jug, Lian-He Yang, Catherine Luedke, Amanda Lo, Pu Su, Xin Liu, Catherine Weaver Rehder, Jerald Z. Gong et al. · 2017 · American Journal of Clinical Pathology
53. Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing
    Lauren Gabriele Banaszak, Valentina Giudice, Xin Zhao, Zhijie Wu, Shouguo Gao, Kohei Thi Hosokawa, Keyvan Keyvanfar, Danielle Michelle Townsley, Fernanda Gutierrez‐Rodrigues, Maria del Pilar Fernandez Ibanez et al. · 2018 · Blood Cells Molecules and Diseases
54. Absorption, distribution, metabolism and excretion of an isocitrate dehydrogenase-2 inhibitor enasidenib in rats and humans
    Zeen Tong, Christian Atsriku, Usha Yerramilli, Xiaomin Wang, Yan Li, Josephine F. Reyes, Bin Fan, Hua Qiang Yang, Matthew Hoffmann, Sekhar Surapaneni · 2018 · Xenobiotica
55. The transcriptome‐wide landscape of molecular subtype‐specific mRNA expression profiles in acute myeloid leukemia
    Tian Mou, Yudi Pawitan Y, Matthias M. S. Stahl, Mattias Vesterlund, Wenjiang Deng, Rozbeh Jafari, Anna Bohlin, Albin Österroos, Loannis Siavelis, Helena Bäckvall et al. · 2021 · American Journal of Hematology
56. The Biology and Management of Cartilaginous Tumors: A Role For Targeting Isocitrate Dehydrogenase
    Gabriel Tinoco, Breelyn Ann Wilky, Ana Cristina Paz-Mejia, Andrew Eric Rosenberg, Jonathan C. Trent · 2015 · American Society of Clinical Oncology Educational Book
57. Advances in genome studies in plants and animals
    R. Appels, Johan Nyström-Persson, Gabriel Keeble‐Gagnère · 2014 · Functional & Integrative Genomics
58. Landscape of Insertion Polymorphisms in the Human Genome
    Masahiro Onozawa, Liat Goldberg, Peter D. Aplan · 2015 · Genome Biology and Evolution
59. Chromatin Dynamics during Differentiation of Myeloid Cells
    Jörg Schönheit, Achim Leutz, Frank Rosenbauer · 2014 · Journal of Molecular Biology
60. Therapy-related AML: A slip of the lip can sink a ship
    Robert Peter Gale, John M. Bennett, F.O. Hoffman · 2014 · Leukemia Research
61. RNA sequencing of sarcomas with simple karyotypes: identification and enrichment of fusion transcripts
    Jakob Hofvander, Johnbosco Tayebwa, Jenny Nilsson, Linda Magnusson, Otte Brosjö, Olle Larsson, Fredrik Vult von Steyern, Henryk A. Domanski, Nils Mandahl, Fredrik Mertens · 2015 · Laboratory Investigation
62. The Genomic and Epigenomic Landscapes of AML
    Luca Mazzarella, Laura Riva, Lucilla Luzi, Chiara Ronchini, Pier Giuseppe Pelicci · 2014 · Seminars in Hematology
63. DSMNC: a database of somatic mutations in normal cells
    Xuexia Miao, Xi Li, Lifei Wang, Caihong Zheng, Jun Cai · 2018 · Nucleic Acids Research
64. Clonal hierarchy of main molecular lesions in acute myeloid leukaemia
    Zdeňka Herudková, Martin Čulen, Adam Folta, Ivana Ježíšková, Jana Černá, Tomáš Loja, Nikola Tom, Jiří Šmejkal, Lukáš Semerád, Dana Dvořáková et al. · 2019 · British Journal of Haematology
65. Studying clonal evolution of myeloid malignancies using induced pluripotent stem cells
    Sergei R. Doulatov, Eirini P. Papapetrou · 2020 · Current Opinion in Hematology
66. DNA Methylation and Intra-Clonal Heterogeneity: The Chronic Myeloid Leukemia Model
    Benjamin Lebecque, Céline Bourgne, Véronique Vidal, Marc Gabriel Berger · 2021 · Cancers
67. Therapy-Related Myeloid Neoplasms in 109 Patients Following Radiation Monotherapy
    Anand Ashwin Patel, Alexandra E. Rojek, Michael William Drazer, Howard Weiner, Lucy A. Godley, Michelle M. Le Beau, Richard A. Larson · 2021 · Blood Advances
68. Clonal hematopoiesis and cardiovascular disease in cancer patients and survivors
    José J. Fuster · 2022 · Thrombosis Research
69. Personalized Therapy for Acute Myeloid Leukemia
    Christopher Simon Hourigan, Judith E. Karp · 2013 · Cancer Discovery
70. Frequency of acute myeloid leukaemia-associated mouse chromosome 2 deletions in X-ray exposed immature haematopoietic progenitors and stem cells
    C.-H. Olme, Natalie Brown, Rosemary Finnon, Simon D Bouffler, Christophe Badie · 2013 · Mutation Research/Genetic Toxicology and Environmental Mutagenesis
71. A personalised medicine approach for ponatinib-resistant chronic myeloid leukaemia
    Koorosh Korfi, Amit Kumar Mandal, Simon J. Furney, Daniel H. Wiseman, Tim C. P. Somervaille, Richard Marais · 2015 · Annals of Oncology
72. In-silico comparison of two induction regimens (7 + 3 vs 7 + 3 plus additional bone marrow evaluation) in acute myeloid leukemia treatment
    Jan Christoph Banck, Dennis Görlich · 2019 · BMC Systems Biology
73. Cellular and molecular architecture of hematopoietic stem cells and progenitors in genetic models of bone marrow failure
    Stephanie C. Heidemann, Brian Bursic, Sasan Zandi, Hongbing Li, Sagi Abelson, Robert J. Klaassen, Sharon B. Abish, Meera S. Rayar, Vicky Rowena Breakey, Houtan Moshiri et al. · 2020 · JCI Insight
74. B7-Positive and B7-Negative Acute Myeloid Leukemias Display Distinct T Cell Maturation Profiles, Immune Checkpoint Receptor Expression, and European Leukemia Net Risk Profiles
    Ion Antohe, Angela Smaranda DASCALESCU, Catalin-Doru Danaila, Amalia-Andrea TITIEANU, Mihaela Zlei, Iuliu Cristian Ivanov, Adriana Sireteanu, Mariana Pavel Tanasa, Petru Cianga · 2020 · Frontiers in Oncology
75. Genetic basis of myelodysplastic syndromes
    Seishi Ogawa · 2020 · Proceedings of the Japan Academy Series B
76. The Changing Landscape of Treatment in Acute Myeloid Leukemia
    Kristin Lynn Koenig, Alice S. Mims, Mark J. Levis, Mary M. Horowitz · 2020 · American Society of Clinical Oncology Educational Book
77. Leptin receptor, a surface marker for a subset of highly engrafting long-term functional hematopoietic stem cells
    Thao Le Phuong Trinh, James P. Ropa, Arafat Aljoufi, Scott H. Cooper, Anthony L. Sinn, Edward F. Srour, Hal E. Broxmeyer · 2020 · Leukemia
78. Discovery of a FLT3 inhibitor LDD1937 as an anti-leukemic agent for acute myeloid leukemia
    Hyo‐Jeong Lee, Jung Eun Lee, Pyeonghwa Jeong, Jungil Choi, Juhwa Baek, Su Jin Ahn, Yeongyu Moon, Jeong‐Doo Heo, Young Hee Choi, Young‐Won Chin et al. · 2017 · Oncotarget
79. In vivo CRISPR/Cas9 screening identifies Pbrm1 as a regulator of myeloid leukemia development in mice
    Bin E. Li, Grace Y. Li, Wenqing Cai, Qian Zhu, Davide Seruggia, Yuko Fujiwara, Christopher R. Vakoc, Stuart H. Orkin · 2023 · Blood Advances
80. Pre-operative clonal hematopoiesis is related to adverse outcome in lung cancer after adjuvant therapy
    Jae Kwang Yun, Sugyeong Kim, Hongyul An, Geun Dong Lee, Hyeong Ryul Kim, Yong‐Hee Kim, Dong Kwan Kim, Seung-Il Park, Sehoon Choi, Youngil Koh · 2023 · Genome Medicine
81. Cell of origin epigenetic priming determines susceptibility to Tet2 mutation
    Giulia Schiroli, Vinay K. Kartha, Fabiana M. Duarte, Trine Ahn Kristiansen, Christina Mayerhofer, Rojesh Shrestha, Andrew Earl, Yan Hu, Tristan Tay, Catherine Rhee et al. · 2024 · Nature Communications
82. Identifying the similarities and differences between single nucleotide polymorphism array (SNPa) analysis and karyotyping in acute myeloid leukemia and myelodysplastic syndromes
    Thiago Rodrigo de Noronha, Sandra Serson Rohr, Maria de Lourdes Chauffaille · 2014 · Revista Brasileira de Hematologia e Hemoterapia
83. Increased expression of ESCO1 is correlated with poor patient survival and its role in human bladder cancer
    Shiying Zhang, Jianye Li, Gaobiao Zhou, Dawei Mu, Jingmin Yan, Jizhang Xing, Zhi-Yong Yao, Haibo Sheng, Di Li, Chao Lv et al. · 2015 · Tumor Biology
84. Genetic profiling in acute myeloid leukemia: a path to predicting treatment outcome
    Giuseppe Visani, Federica Loscocco, Alessandro Isidori, Pier Paolo Piccaluga · 2018 · Expert Review of Hematology
85. Genetic and epigenetic factors interacting with clonal hematopoiesis resulting in chronic myelomonocytic leukemia
    Ryan Michael Carr, Mrinal M. Patnaik · 2019 · Current Opinion in Hematology
86. Epigenetic activation of O-linked β-N-acetylglucosamine transferase overrides the differentiation blockage in acute leukemia
    Kerstin Maria Kampa-Schittenhelm, T. Haverkamp, M. Bonin, Vasileia Tsintari, Hans‐Jörg Bühring, Lara Annina Haeusser, Gunnar Blumenstock, Simone Dreher, Tariq A. Ganief, Figen Akmut et al. · 2020 · EBioMedicine
87. OTS167 blocks FLT3 translation and synergizes with FLT3 inhibitors in FLT3 mutant acute myeloid leukemia
    Bartholomew J. Eisfelder, Caner Saygin, Joseph P. Wynne, Maggie Colton Cove, Mariafausta Fischietti, Elspeth M. Beauchamp, Jason Xiaojun Cheng, Olatoyosi M. Odenike, Gail J. Roboz, Houda Alachkar et al. · 2021 · Blood Cancer Journal
88. GW5074 and PP2 kinase inhibitors implicate nontraditional c-Raf and Lyn function as drivers of retinoic acid-induced maturation
    Holly A. Jensen, Rodica Petruta Bunaciu, Jeffrey D. Varner, Andrew Yen · 2015 · Cellular Signalling
89. Therapy-Related Clonal Hematopoiesis
    Yoshimitsu Yura, Jesse D. Cochran, Kenneth X. Walsh · 2022 · Heart Failure Clinics
90. Game of clones: Diverse implications for clonal hematopoiesis in lymphoma and multiple myeloma
    Jeremy Meier, Jeffrey Lee Jensen, Christopher E. Dittus, Catherine Callaghan Coombs, Samuel M. Rubinstein · 2022 · Blood Reviews
91. The spectrum of somatic mutations in large granular lymphocyte leukemia, rheumatoid arthritis, and Felty's syndrome
    Paula Savola, Dipabarna Bhattacharya, Jani Huuhtanen · 2022 · Seminars in Hematology
92. Molecular Genetic Biomarkers in Myeloid Malignancies
    Anna P. Matynia, Philippe Szankasi, Wei Shen, Todd W. Kelley · 2014 · Archives of Pathology & Laboratory Medicine
93. Heterogeneity of clonal expansion and maturation-linked mutation acquisition in hematopoietic progenitors in human acute myeloid leukemia
    Roland B. Walter, G S Laszlo, Jack M. Lionberger, J A Pollard, Kimberly H. Harrington, Chelsea J. Gudgeon, Megan K. D. Othus, Shahin Rafii, Soheil Meshinchi, Frederick R. Appelbaum et al. · 2014 · Leukemia
94. Leveraging Cancer Genome Information in Hematologic Malignancies
    Raajit K. Rampal, Ross L. Levine · 2013 · Journal of Clinical Oncology
95. Mapping epigenetic regulator gene mutations in cytogenetically normal pediatric acute myeloid leukemia
    Daria G. Valerio, Jenny E. Katsman-Kuipers, Joop H. Jansen, Lonneke Verboon, Válerie de Haas, Jan Starý, André Baruchel, M Zimmermann, Rob Pieters, Dirk Reinhardt et al. · 2014 · Haematologica
96. Clonal evolution detected with conventional cytogenetic analysis is a potent prognostic factor in adult patients with relapsed AML
    Hiroaki Shimizu, Akihiko Yokohama, Takuma Ishizaki, Nahoko Hatsumi, Satoru Takada, Takayuki Saitoh, Toru Sakura, Yoshihisa Nojima, Hiroshi Handa · 2017 · Hematological Oncology
97. Dasatinib synergizes with ATRA to trigger granulocytic differentiation in ATRA resistant acute promyelocytic leukemia cell lines via Lyn inhibition-mediated activation of RAF-1/MEK/ERK
    Ming Ding, Xiangqin Weng, Yan Sheng, Jing Wu, Liang Cui, Xun Cai · 2017 · Food and Chemical Toxicology
98. Normal and leukemic stem cell niche interactions
    Il‐Hoan Oh, Seon‐Yeong Jeong, Jin‐A Kim · 2019 · Current Opinion in Hematology
99. L’hématopoïèse clonale : un concept émergent à la croisée des spécialités
    François‐Xavier Danlos, Matthias Papo, Jean‐Baptiste Micol · 2019 · La Revue de Médecine Interne
100. Conformational modifications induced by internal tandem duplications on the FLT3 kinase and juxtamembrane domains
     Guido Todde, Ran Friedman · 2019 · Physical Chemistry Chemical Physics